Workflow
PAYONEER GLEQ.WARRT.EXP(PAYOW) - 2025 Q4 - Annual Report
2026-02-26 21:07
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. Payoneer Global Inc. (Exact name of registrant as specified in its charter) 001-40547 (Commission file number) Delaware 86-1778671 (St ...
Payoneer (PAYO) - 2025 Q4 - Annual Report
2026-02-26 21:07
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. Payoneer Global Inc. (Exact name of registrant as specified in its charter) 001-40547 (Commission file number) Delaware 86-1778671 (St ...
DiamondRock Hospitality pany(DRH) - 2025 Q4 - Annual Results
2026-02-26 21:07
COMPANY CONTACTS Briony Quinn Chief Financial Officer (240) 744-1196 Dori Kesten Capital Markets (617) 835-8366 DIAMONDROCK HOSPITALITY COMPANY REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS Comparable Total RevPAR Growth, Adjusted EBITDA, and Adjusted FFO Per Share Exceed High End of Guidance BETHESDA, Maryland, Thursday, February 26, 2026 – DiamondRock Hospitality Company (Nasdaq: DRH, the "Company"), a lodging real estate investment trust that owns a portfolio of 35 premium hotels and resorts in the U ...
Clover Health Investments(CLOV) - 2025 Q4 - Annual Results
2026-02-26 21:07
Exhibit 99.1 Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance Business Highlights: Financial Results: Full Year 2026 Guidance: WILMINGTON, Del. – February 26, 2026 – Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), today reported financial results for the fourth quarter and full year 2025. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights. "Our ...
PubMatic(PUBM) - 2025 Q4 - Annual Results
2026-02-26 21:07
Financial Performance - FY 2025 revenue was $282.9 million, a decrease from $291.3 million in FY 2024[6] - Adjusted EBITDA for FY 2025 was $61.6 million, representing a 22% margin, down from $92.3 million and 32% margin in FY 2024[6] - Fourth quarter revenue was $80.0 million, compared to $85.5 million in Q4 2024[12] - GAAP net income for Q4 2025 was $6.7 million, down from $13.9 million in Q4 2024[12] - Gross profit for the year ended December 31, 2025, was $179,841,000, down from $190,229,000 in 2024, reflecting a decline of 5.5%[34] - Net loss for the year ended December 31, 2025, was $(14,462,000), compared to a net income of $12,504,000 in 2024[34] - Operating income for Q4 2025 was $8,524,000, down from $14,802,000 in Q4 2024, representing a decline of 42.2%[34] - Revenue for Q4 2025 was $80,046, a decrease from $85,502 in Q4 2024, with total revenue for 2025 at $282,926 compared to $291,256 in 2024[39] - Adjusted EBITDA for Q4 2025 was $27,818, down from $37,646 in Q4 2024, with a full year adjusted EBITDA of $61,640 for 2025 compared to $92,325 in 2024[39] - Non-GAAP net income for Q4 2025 was $14,440, compared to $21,443 in Q4 2024, with full year non-GAAP net income of $16,701 for 2025 versus $42,452 in 2024[39] Cash Flow and Assets - Free cash flow in FY 2025 was $46.2 million, an increase of 32% over FY 2024[6] - Total cash, cash equivalents, and marketable securities at the end of FY 2025 were $145.5 million, a 4% increase from FY 2024[6] - Cash and cash equivalents increased to $145,518,000 in 2025 from $100,452,000 in 2024, an increase of 44.8%[32] - Net cash provided by operating activities for Q4 2025 was $18,159, slightly up from $18,048 in Q4 2024, with total operating cash flow for 2025 at $81,059 compared to $73,425 in 2024[41] - Free cash flow for Q4 2025 was $6,852, down from $8,856 in Q4 2024, with total free cash flow for 2025 at $46,203 compared to $34,897 in 2024[41] Shareholder Actions - The company repurchased 4.1 million shares in 2025, representing 8.1% of fully diluted shares[1] - Total stock-based compensation for 2025 was $38,378, compared to $37,676 in 2024, indicating a slight increase in compensation expenses[39] Future Guidance - For Q1 2026, revenue is expected to be between $58 million and $60 million, with adjusted EBITDA guidance of $(0.5) million to $1.0 million[23] - The company expects to provide guidance for revenue and adjusted EBITDA for Q1 2026, indicating a focus on future growth[28] Market Performance - CTV revenue grew over 50% year-over-year in FY 2025, excluding political ad spend[17] - Net dollar-based retention rate for FY 2025 was 96%, indicating strong publisher satisfaction[6] Innovation and Strategy - The company continues to innovate in programmatic advertising, leveraging AI-driven optimization and privacy-focused solutions[29]
Omnicell(OMCL) - 2025 Q4 - Annual Report
2026-02-26 21:07
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________ FORM 10-K (Mark One) For the transition period from to Commission File No. 000-33043 OMNICELL, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 94-3166458 (IRS Employer Identification No.) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANG ...
Evertec(EVTC) - 2025 Q4 - Annual Results
2026-02-26 21:07
Exhibit 99.1 • Revenue grew 10.2% to $931.8 million, approximately 10.9% on a constant currency basis • GAAP Net Income attributable to common shareholders was $141.6 million an increase of 25.7%, or $2.20 per diluted share • Adjusted EBITDA was $373.4 million an increase of 9.7% and Adjusted earnings per common share increased by 10.4% to $3.62 • $82.1 million returned to shareholders through share repurchases and dividends • Increased and extended share repurchase program EVERTEC REPORTS FOURTH QUARTER AN ...
Beamr Imaging .(BMR) - 2025 Q4 - Annual Report
2026-02-26 21:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 (Exact name of registrant as specified in its charter) FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR ...
Flutter Entertainment(FLUT) - 2025 Q4 - Annual Results
2026-02-26 21:07
Exhibit 99.1 Q4 AND FY 2025 EARNINGS February 26,2026 Flutter Entertainment Reports Fourth Quarter and Full Year 2025 Financial Results February 26, 2026 (New York): Flutter Entertainment (NYSE:FLUT; LSE:FLTR), the world's leading online sports betting and iGaming operator, announces Q4 and full year 2025 results, and introduces 2026 guidance. Unparalleled scale advantages and strategic execution reinforced Flutter's global leadership in 2025 Key financial highlights: | | | Three months ended December 31 | ...
TeraWulf (WULF) - 2025 Q4 - Annual Results
2026-02-26 21:07
Contracted 522 critical IT MW totaling over $12.8 billion of revenue 1 Secured full funding for contracted capacity with construction advancing in alignment with tenant deployment timelines Multi-year development pipeline enables targeted annual delivery of 250 - 500 critical IT MW through the end of the decade EASTON, Md. – February 26, 2026 – TeraWulf Inc. (Nasdaq: WULF) ("TeraWulf" or the "Company"), an owner, developer, and operator of energy-advantaged digital infrastructure purpose-built for high-perf ...